Basic Information | Post buying leads | Suppliers | Cas Database |
Product Name: beta-Cyclodextrin,2A,2B,2C,2D,2E,2F,2G,6A,6B,6C,6D,6E,6F,6G-tetradeca-O-methyl-
Molecular Structure:
Molecular Formula: C56H98O35
Molecular Weight: 1331.3563
Synonyms of beta-Cyclodextrin,2A,2B,2C,2D,2E,2F,2G,6A,6B,6C,6D,6E,6F,6G-tetradeca-O-methyl- (CAS NO.51166-71-3): Dimethyl-beta-cyclodextrin ; Heptakis-2,6-di-O-methyl-beta-cyclodextrin
CAS NO: 51166-71-3
Melting Point: 298-310 °C
Index of Refraction: 1.552
Molar Refractivity: 303.74 cm3
Molar Volume: 949.6 cm3
Surface Tension: 61.1 dyne/cm
Density: 1.4 g/cm3
Flash Point: 681.7 °C
Enthalpy of Vaporization: 201.55 kJ/mol
Boiling Point of beta-Cyclodextrin,2A,2B,2C,2D,2E,2F,2G,6A,6B,6C,6D,6E,6F,6G-tetradeca-O-methyl- (CAS NO.51166-71-3): 1203.6 °C at 760 mmHg
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD | intravenous | > 150mg/kg (150mg/kg) | Journal of Inclusion Phenomena. Vol. 1, Pg. 135, 1983. | |
mouse | LD | oral | > 3gm/kg (3000mg/kg) | Journal of Inclusion Phenomena. Vol. 1, Pg. 135, 1983. | |
rat | LD50 | intravenous | 220mg/kg (220mg/kg) | Journal of Inclusion Phenomena. Vol. 1, Pg. 135, 1983. | |
rat | LD50 | subcutaneous | 350mg/kg (350mg/kg) | Journal of Inclusion Phenomena. Vol. 1, P |
Safety Statements of beta-Cyclodextrin,2A,2B,2C,2D,2E,2F,2G,6A,6B,6C,6D,6E,6F,6G-tetradeca-O-methyl- (CAS NO.51166-71-3): 24/25
S24/25: Avoid contact with skin and eyes.
WGK Germany: 3
RTECS: GU2293500